Insider Holders & Insider Ownership - Atara Biotherapeutics Inc. (ATRA)

List of insiders holdings for Atara Biotherapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
SEIDENBERG BETH C
Director
2023-06-02 20:06:15195,189
1,877,044
2,072,233Form 4
Kleiner Perkins Caufield & Byers XV LLC
KPCB XV Associates LLC
KPCB XV Founders Fund LLC
10% Owner
2019-02-14 13:49:251,876,650
0
1,876,650Form 13G
Domain Partners VIII L.P.
BLAIR JAMES C
DOVEY BRIAN H
TREU JESSE I
SCHOEMAKER KATHLEEN K
VITULLO NICOLE
Halak Brian K
10% Owner
2016-01-19 16:03:051,641,542
0
1,641,542Form 13G
DAG Ventures Management V LLC
Cadeddu John J.
Goodrich R. Thomas
Pianim Nicholas K.
Chung Young J.
Williams Greg
DAG Ventures V-QP L.P.
DAG Ventures V L.P.
10% Owner
2019-02-07 16:45:001,581,166
0
1,581,166Form 13G
Adiumentum Capital Fund I LP
Adiumentum Capital Fund I GP LLC
Ciongoli Gregory Austin
Director
10% Owner
2024-09-05 18:42:081,284,016
0
1,284,016Form 3
MARCUS JOEL S
Director
2019-03-19 16:19:257,500
892,355
899,855Form 4
Gallagher Carol Giltner
Director
2024-04-02 18:12:10629,608
0
629,608Form 4
Ciechanover Isaac E.
Chief Executive Officer
2019-05-31 16:16:00332,243
290,687
622,930Form 4
DOBMEIER ERIC
Director
2023-11-14 18:27:14563,325
0
563,325Form 4
HEIDEN WILLIAM K
Director
2024-04-02 18:12:47359,000
0
359,000Form 4
Haqq Christopher
EVP, R&D & Chief Scientific Of
2019-02-19 17:08:22271,943
20,000
291,943Form 4
Dupont Jakob
EVP, Head of R&D
2023-03-06 18:46:39290,794
0
290,794Form 4
Banard Charlene A.
EVP, Chief Technical Officer
2023-05-18 20:17:21276,010
0
276,010Form 4
Fust Matthew K
Director
2024-04-02 18:13:10259,000
0
259,000Form 4
Yarema Kristin
Chief Commercial Officer
2022-03-03 19:02:35257,007
0
257,007Form 4
Soffer Gad
EVP & Chief Strategy Officer
2018-09-25 16:17:01243,966
0
243,966Form 4
Roncarolo Maria Grazia
Director
2024-04-02 18:12:27238,500
0
238,500Form 4
MALLIK AMEET
Director
2024-04-02 18:11:52227,500
0
227,500Form 4
Koppikar Utpal
Chief Financial Officer
2023-03-06 18:47:31181,978
0
181,978Form 4
Joshi Manher
EVP, Chief Medical Officer
2023-11-20 17:30:19171,284
0
171,284Form 4
Newell Joe
Chief Operations Officer
2021-11-18 17:54:29113,097
0
113,097Form 4
Clark Mitchall G.
EVP & Chief R & QA Officer
2018-05-21 18:32:34107,972
0
107,972Form 4
MCGRATH JOHN
EVP & Chief Financial Officer
2018-03-20 18:30:3688,762
0
88,762Form 4
Berger Dietmar
Global Head of R&D
2019-05-08 16:32:3285,678
0
85,678Form 4
Nguyen AnhCo
President and CEO
2024-11-20 18:04:0077,454
0
77,454Form 4
Baynes Roy D.
Director
2022-06-27 16:48:0975,000
0
75,000Form 4
Touchon Pascal
President and CEO
2024-08-20 18:27:5870,127
0
70,127Form 4
Turner Heather D
Former EVP, GC & Sec.
2018-02-12 21:00:0769,494
0
69,494Form 4
Kim Mina
Senior VP & General Counsel
2019-04-10 16:33:3066,389
0
66,389Form 4
Renaud Ronald C JR
Director
2022-06-27 16:48:0163,000
0
63,000Form 4
Porter Derrell
SVP, Head of Global Commercial
2019-03-27 17:17:2031,688
0
31,688Form 4
Murugan Amar
EVP, Chief Legal Officer
2024-08-20 18:27:2626,827
0
26,827Form 4
WEBER ECKARD
Director
2015-01-21 16:38:2525,000
0
25,000Form 4
Hyllengren Eric J
EVP, CFO and COO
2024-11-20 18:04:5923,392
0
23,392Form 4
Henrich Jill
EVP, Chief Regulatory Officer
2024-11-20 18:05:4919,378
0
19,378Form 4
DP VIII Associates L.P.
BLAIR JAMES C
DOVEY BRIAN H
TREU JESSE I
SCHOEMAKER KATHLEEN K
VITULLO NICOLE
Halak Brian K
10% Owner
2014-10-21 10:39:2615,890
0
15,890Form 4